Bio-Techne (NASDAQ:TECH) Downgraded to Hold at Zacks Investment Research
Zacks Investment Research downgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a buy rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as […]